• Zenas BioPharma granted inducement equity awards dated June 15, 2026 to newly hired employees: stock options for 100,000 shares, RSUs for 78,075 shares.
• Options carry a 10-year term, $18.71 exercise price, vesting over four years with 25% after one year, then monthly installments.
• RSUs vest in four equal tranches on June 15 of 2027 through 2030, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606171615PRIMZONEFULLFEED9748607) on June 17, 2026, and is solely responsible for the information contained therein.